and Tobacco Control Act (FDA, 2015) . Specifically, FDA held that such labels violate Section 911 of the Act, which relates to Modified Risk Tobacco Products. That is, the claims of "natural" and "additive-free" imply that "the products or their smoke do not contain or are free of a substance and/or that the products present a lower risk of tobacco-related disease or are less harmful than one or more other commercially marketed tobacco products" (FDA, 2015) . Such claims are required to be preevaluated by the FDA on the basis of scientific evidence that the product reduces risk/exposure for smoking-related diseases and benefits the population as a whole (FDA, 2012) . The FDA also noted in its warning letters to SFNTC and Imperial (which acquired Winston in the Reynolds-Lorillard merger) that the 1999 consent agreement with the FTC does not shield them from FDA enforcement of provisions of the Act (FDA, 2015) .
The current study aimed to examine whether cigarettes promoted as "natural" or "additive-free" are perceived as less hazardous compared with other cigarettes in general, and how consumers respond to a specific ad for one brand featuring such a promotion. This study was conducted before the FDA action took place and addresses misperceptions garnered by the labeling and advertising of a brand (NAS) that was a subject of the FDA's warning letters. An important point of distinction from the existing literature is that we incorporate measures of unprompted risk perceptions as well as responses to a specific product advertisement, all conducted in a large sample with a wide age and smoking experience range.
Method
A web-based survey was conducted in 2013 among 3,006 U.S.-based panel members recruited from GMI-MR/ Lightspeed Research (www.lightspeedgmi.com). In brief, the GMI-MR/Lightspeed panel is a double opt-in commercial consumer research panel, wherein panelists apply for membership and then respond to an email to verify their information. As such, it is not compiled by traditional survey sampling techniques, nor is the sample selected to be nationally representative. Our sample included adolescents aged 15 to 17 years recruited via parent panel members as well as adults (>18 years). Further details of the survey design and methods are described elsewhere . The study protocol was approved by the Institutional Review Board of Roswell Park Cancer Institute. The larger survey focused on reactions to relative health claims embedded in ads for Camel Snus versus Nicorette gum, with a NAS ad included as a comparison product (see Supplemental Figure 1 for advertisement used in the study, available online with this article).
Measures
Smoking status was assessed as never smoker (never smoked, even a few puffs), ever/former smoker (smoked in the past, not currently smoking), and current smoker (now smoking daily or on some days). Items used to assess product health risks are shown in Table 1 . These items were asked before the advertising manipulation. For analysis purposes, the rating for cigarettes labeled "natural" or "additive-free" (herein referred to as "Natural") was assessed singly, while the scores for the remaining cigarette types ("unfiltered," "full-flavor," "light," "ultralight") were averaged (Cronbach's α = .91). We then calculated a difference score between product health risk ratings of Natural cigarettes and the average of other cigarette types, which served as our measure of misperception (more positive scores indicate that Natural is perceived as less harmful). Perceived disease risk was evaluated by asking about selfassessed risk for nine smoking-associated diseases relative to a nonsmoker (e.g., lung cancer). A summary score was derived for use in analysis (Cronbach's α = .98) by summing the nine items. After seeing the ad, participants were asked to rate the ad on measures of truthfulness, skepticism of the claim, and claim content. We created a summary scale of ad belief by summing truthfulness and skepticism (reverse-coded). Emotional valence (i.e., positive vs. negative response) and arousal were assessed using the Self-Assessment Manikin (Bradley & Lang, 1994) . After seeing all ads, participants were asked to select which product they would most like to try (forced choice among NAS, Camel Snus, and Nicorette), and for that selected product rate their intention to purchase on a 1 to 10 scale (Juster, 1966) .
Statistical Approach
Data were initially characterized using descriptive statistics. Misperception of cigarette risks and ad belief were modeled using linear regression, while purchase intention was assessed using logistic regression. Multivariate models adjusted for smoking status, age, sex, race, and level of education. All analyses were conducted using SPSS v21 (IBM, Armonk, NY).
Results

Participant Demographics
Overall, 53% of participants were female, 68% were nonHispanic White, 12% Black, 45% with high school education or less, 33% aged 15 to 17 years, 16% aged 18 to 34 years, and 51% aged 35 years or older. Current smokers comprised 25% of the sample, while 44.3% were never smokers.
Misperceptions of Natural Cigarette Health Risks
The geometric mean misperception score for cigarette brands described as "natural" or "additive-free" (described from here on as Natural) was 2.2, compared with the 2.0 score for other cigarettes, meaning that Natural cigarettes were perceived as having slightly less risk to health (p < .001 by signed rank test). The arithmetic mean difference score was 0.38 (SD = 1.0). Across the sample, 44.7% of respondents had difference scores of 0 (indicating no difference in perceived risk), 15% had negative scores (indicating Natural was perceived as more harmful than other cigarettes), and 40.3% had positive scores (indicating Natural was perceived as less harmful than other cigarettes). Regression analysis was used to examine correlates of Natural misperceptions, with smoking status, sex, age, race, education, and perceived disease risks scale simultaneously entered into the model. Controlling for other factors, never smokers (B = −0.31, p < .001) and ever/former smokers (B = −0.15, p = .002) had significantly less misperception of the risk of Natural cigarettes than daily/nondaily smokers. Post hoc tests with the Bonferroni correction showed that all three groups were different at the p < .007 level. The other entered factors did not show significant relationships with Natural perceptions.
Ad Response
After viewing the NAS ad with its marketing claim of "additive-free, natural tobacco," participants completed items assessing their perceptions of the ad. Forty-two percent perceived the ad as truthful, and 13% said they were not at all skeptical of the ad. Sixty percent of respondents said the ad claimed American Spirit had no risk or was less risky than other tobacco products. Cross-tabulation showed that those who believed that Natural cigarettes posed less risk were no more or less likely to agree the NAS ad claimed no or less 
Purchase Intention
Across all participants, 22% (N = 655) selected NAS as the product they would most like to try. Of these, 48% (N = 315) said they had "no chance" of purchasing the product in the next month. Therefore, of all participants, 11% (N = 340) said they had at least some intention to purchase NAS in the next month; the vast majority were current smokers (N = 264), with smaller numbers of former (N = 49) and never (N = 27) smokers. (Only 9 respondents reported NAS as their usual brand.) We modeled purchase intention for NAS versus any other selection as a function of demographics, ad reactions, and perceived risks using logistic regression. Results are presented in Table 2 . Overall, current smokers were substantially more likely to report an intention to purchase NAS than never smokers (odds ratio [OR] = 17.8), as were ever smokers (OR = 2.4). Because of this, we ran additional models stratified by smoking status. Greater belief that the NAS ad was truthful was associated with greater odds of expressing NAS purchase intention (OR = 1.2), particularly among never smokers (OR = 1.4). More positive affective response (OR = 2.1) and greater emotional arousal (OR = 1.3) after seeing the ad were positively associated with purchase intention. Positive affective response appeared to be a consistent predictor regardless of smoking status, but emotional arousal appeared to be significant only for ever or current smokers (see Table 2 ). Finally, more misperceptions about Natural cigarette health risks were associated with greater NAS purchase intention (OR = 1.13), controlling for other factors. Interestingly, the misperception effect was strongest among Never smokers (OR = 1.4). Perceived smoking-related disease risk was not associated with intention to purchase NAS cigarettes. Sex, race, age, or education did not have significant independent relationships to NAS purchase intention.
Discussion
The findings from this study are consistent with other published studies (Agaku et al., 2014; Arnett, 1999; Czoli & Hammond 2014; Kelly & Manning, 2014; McDaniel & Malone, 2007) showing that consumers perceive that cigarettes promoted as "natural" or "additive-free" are less harmful than other cigarettes. The current research demonstrated that this belief influenced perceptions of advertising for NAS cigarettes and increased the likelihood that participants would express an intention to purchase NAS, even controlling for other factors. Nonsmokers in the current sample were less likely to believe that "natural" or "additive-free" cigarettes were less harmful, but those who did harbor these misperceptions and perceived the ad as truthful were more likely to express purchase intention. The 1999 FTC consent agreement disclaimers and subsequent agreements with state Attorneys General to include disclaimers on organic products have done little to correct misperceptions. Indeed, the NAS ad presented to participants in the current study contained these disclaimers, yet 60% read the ad as claiming that NAS had either no risk or less risk than other products, and nearly half viewed the ad as truthful. Although other brands such as Nat Sherman and Winston also have leveraged claims of "all natural" and "additive-free" as points of difference, NAS is the leader in brand share and by far the most active in advertising and promotions. In the first 9 months of 2015, NAS's claim of "100% Additive-Free Natural Tobacco" appeared in ads in popular magazines such as Playboy, Rolling Stone, Vanity Fair, Out, and Car and Driver, as well as direct mail distributed to those in the brand's database (Trinkets and Trash, 2015) . It is likely that the brand's positioning and marketing has contributed to its rising market share. Japan Tobacco International purchased the international rights to NAS from Reynolds-American for $5 billion, citing its growth opportunities (Yui & Chambers, 2015) .
Overall, this secondary analysis (using data collected well before FDA's warning letters) indicates that consumers hold misperceptions of cigarettes promoted as "natural" and "additive-free," and that these misperceptions are independently associated with intentions to purchase the NAS brand, the most widely promoted exemplar. Furthermore, despite a specific disclaimer in the ad, most participants viewed the American Spirit ad as claiming the product to be safe or safer than other products. So far, the FDA has taken no further public action related to NAS marketing beyond its initial warning letter sent to SFNTC in August 2015. Reynolds-American and its subsidiary SFNTC have stated publicly that it had sent a response to FDA's warning letter about its NAS marketing (Craver, 2015) , but it does not appear that the misleading marketing of NAS has been discontinued. For example, a review of advertisements made available online by Trinkets and Trash shows that the main marketing messages for NAS have not changed since the warning letter. Thus, millions of Note. NAS = Natural American Spirit; aOR = adjusted odds ratio; LCL = lower confidence limit; UCL = upper confidence limit. Bolded values are statistically significant at the p < .05 level. Models also adjusted for sex, age, race, and education level.
consumers continue to be knowingly misled by the marketing of NAS. The lack of public action by the FDA to stop the misleading marketing of NAS is disappointing, but may be reflective of a broader pattern of FDA actions, which appear to prioritize product authorizations over product removals (cf. Jenson, Lester, & Berman, 2016) . In this case, a product that implicitly suggests reduced harm to consumers has been allowed to remain on the market, even after the FDA has warned its manufacturer of potential violations.
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